FUNDAMENTALS · Fundamentals · JP Basic Materials

DKS (4461) Fundamentals 2026 — P/E 18.3x, Revenue Analysis | SniperIQ

DKS (4461) is a JP-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥116.6B, trading at ¥10990.00 on the JPX. This SniperIQ fundamentals page covers DKS's valuation (P/E 18.3x, P/B 2.2x), profitability (net margin 7.4%), revenue (¥82.9B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap¥116.6B
P/E (TTM)18.3x
Net Margin7.4%
Revenue (FY26)¥82.9B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is DKS's market cap?

DKS (4461) has a market capitalization of approximately ¥116.6B, trading at ¥10990.00 on the JPX. Market cap moves with the live share price.

What is DKS's P/E ratio?

DKS's trailing twelve-month P/E ratio is 18.3x, with a price-to-book (P/B) of 2.2x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.

How profitable is DKS?

DKS runs a net profit margin of 7.4%, a gross margin of 29.9%, and an operating margin of 12.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does DKS generate?

DKS reported revenue of ¥82.9B for fiscal year 2026, with net income of ¥6.2B and earnings per share (EPS) of 606.24. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does DKS pay a dividend?

DKS offers a trailing dividend yield of about 1.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is DKS financially healthy?

DKS carries a debt-to-equity ratio of 0.56x and a current ratio of 1.75x, with a market beta of 1.25. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is DKS a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For DKS (4461) the key facts are: market cap ¥116.6B, P/E 18.3x, revenue ¥82.9B, 52-week range 4295-13540. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.

Track DKS's full fundamentals live

Get DKS's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Takasago International (4914) fundamentals · Kyungin Synthetic (012610) fundamentals · Jubilant Ingrevia (JUBLINGREA) fundamentals · Hengli Petrochemical (600346) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons